IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 112 filers reported holding IMMUNOMEDICS INC in Q2 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $194,312,000 | +130.0% | 2,285,218 | -4.2% | 0.04% | +76.2% |
Q2 2020 | $84,499,000 | +299.9% | 2,384,286 | +52.1% | 0.02% | +250.0% |
Q1 2020 | $21,130,000 | -51.4% | 1,567,511 | -23.8% | 0.01% | -50.0% |
Q4 2019 | $43,521,000 | +3.2% | 2,056,723 | -35.3% | 0.01% | -20.0% |
Q3 2019 | $42,180,000 | -52.7% | 3,180,991 | -50.5% | 0.02% | +36.4% |
Q2 2019 | $89,181,000 | +188.7% | 6,429,818 | +299.9% | 0.01% | -15.4% |
Q1 2019 | $30,887,000 | -44.3% | 1,607,882 | -58.6% | 0.01% | -40.9% |
Q4 2018 | $55,421,000 | -22.1% | 3,883,737 | +13.7% | 0.02% | -4.3% |
Q3 2018 | $71,124,000 | +1.1% | 3,414,452 | +14.9% | 0.02% | -8.0% |
Q2 2018 | $70,331,000 | +99.5% | 2,971,309 | +23.1% | 0.02% | +92.3% |
Q1 2018 | $35,255,000 | -26.6% | 2,412,981 | -18.8% | 0.01% | -23.5% |
Q4 2017 | $48,035,000 | +63.7% | 2,972,472 | +41.6% | 0.02% | +54.5% |
Q3 2017 | $29,350,000 | +147.4% | 2,099,459 | +56.3% | 0.01% | +120.0% |
Q2 2017 | $11,863,000 | +71.2% | 1,343,500 | +25.5% | 0.01% | +66.7% |
Q1 2017 | $6,929,000 | +140.1% | 1,070,900 | +36.2% | 0.00% | +200.0% |
Q4 2016 | $2,886,000 | +84.3% | 786,422 | +63.2% | 0.00% | – |
Q3 2016 | $1,566,000 | -13.5% | 481,741 | -38.3% | 0.00% | – |
Q2 2016 | $1,810,000 | +64.7% | 780,229 | +77.5% | 0.00% | – |
Q1 2016 | $1,099,000 | -74.0% | 439,600 | -68.0% | 0.00% | -100.0% |
Q4 2015 | $4,220,000 | +145.8% | 1,374,609 | +37.7% | 0.00% | – |
Q3 2015 | $1,717,000 | -75.5% | 998,324 | -42.2% | 0.00% | -100.0% |
Q2 2015 | $7,013,000 | +43.0% | 1,727,365 | +34.9% | 0.00% | 0.0% |
Q1 2015 | $4,904,000 | -13.9% | 1,280,281 | +7.9% | 0.00% | -33.3% |
Q4 2014 | $5,697,000 | +15.4% | 1,187,024 | -10.5% | 0.00% | +50.0% |
Q3 2014 | $4,936,000 | -14.5% | 1,326,942 | -16.1% | 0.00% | -33.3% |
Q2 2014 | $5,773,000 | -17.9% | 1,581,699 | -5.3% | 0.00% | -25.0% |
Q1 2014 | $7,030,000 | -39.4% | 1,669,651 | -33.8% | 0.00% | -20.0% |
Q4 2013 | $11,604,000 | -21.2% | 2,522,543 | +6.0% | 0.01% | -28.6% |
Q3 2013 | $14,724,000 | +37.3% | 2,378,796 | +20.6% | 0.01% | +16.7% |
Q2 2013 | $10,727,000 | – | 1,971,724 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |